Effects of camptothecin, a topoisomerase I inhibitor, on Plasmodium falciparum

Biochemical Pharmacology

Volumn 55, Issue 5, 1998, Pages 709-711

  Bodley, Annette L ^a   Cumming, Jared N ^b   Shapiro, Theresa A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Camptothecin; Malaria; Plasmodium falciparum; Topoisomerase

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR;

ARTICLE; CYTOTOXICITY; IN VITRO STUDY; NUCLEIC ACID SYNTHESIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; CAMPTOTHECIN; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; ERYTHROCYTES; PLASMODIUM FALCIPARUM;

EID: 18844479929     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00556-X     Document Type: Article

References (16)

1. 1. Butler D, Maurice J and O'Brien C, Time to put malaria control on the global agenda. Nature 386: 535-536, 1997.
2. 2. Hoffman SL, Artemether in severe malaria - Still too many deaths. N Engl J Med 335: 124-126, 1996.
3. 3. Schneider E, Hsiang Y-H and Liu LF, DNA topoisomerases as anticancer drug targets. Adv Pharmacol 21: 149-183, 1990.
4. 4. Drlica K and Kreiswirth B, 4-Quinolones and the physiology of DNA gyrase. Adv Pharmacol 29A: 263-283, 1994.
5. 5. Wang JC, DNA topoisomerases. Annu Rev Biochem 65: 635-692, 1996.
6. 6. Wall ME and Wani MC, Camptothecin and analogs: From discovery to clinic. In: Camptothedns: New Anticancer Agents (Eds. Potmesil M and Pinedo H), pp. 21-41. CRC Press, Boca Raton, 1995.
7. 7. Nitiss J and Wang JC, DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci USA 85: 7501-7505, 1988.
8. 8. Riou J-F, Gabillot M, Philippe M, Schrevel J and Riou G, Purification and characterization of Plasmodium berghei DNA topoisomerase I and II: Drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage. Biochemistry 25: 1471-1479, 1986.
9. 9. Cheesman S, McAleese S, Goman M, Johnson D, Horroks P, Ridley RG and Kilbey BJ, The gene encoding topoisomerase II from Plasmodium falciparum. Nucleic Adds Res 22: 2547-2551, 1994.
10. 10. Tosh K and Kilbey B, The gene encoding topoisomerase 1 from the human malaria parasite Plasmodium falciparum. Gene 163: 151-154, 1995.
11. 11. Trager W and Jensen JB, Human malaria parasites in continuous culture. Science 193: 673-675, 1976.
12. 12. Desjardins RE, Canfield CJ, Haynes JD and Chulay JD, Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710-718, 1979.
13. 13. Posner GH, González L, Cumming JN, Klinedinst D and Shapiro TA, Synthesis and antimaiarial activity of heteroatom-containing bicyclic endoperoxides. Tetrahedron 53: 37-50, 1997.
14. 14. Bodley AL and Shapiro TA, Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania. Proc Natl Acad Sci USA 92: 3726-3730, 1995.
15. 15. Geary TG, Divo AA and Jensen JB, Activity of quinoline-containing antimalarials against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 81: 499-503, 1987.
16. 16. Chen AY, Yu C, Potmesil M, Wall ME, Wani MC and Liu LF, Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells. Cancer Res 51: 6039-6044, 1991.